
|Videos|March 8, 2022
Dr. Rogers discusses FDA approval of InterStim X system
Author(s)Urology Times staff
The device is indicated for overactive bladder, chronic fecal incontinence, and non-obstructive urinary retention.
Advertisement
In this video, Alexandra Rogers, MD, comments on the recent FDA approval of the InterStim X system. Rogers is a urologist in Boulder, Colorado.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
2
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
3
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
4
FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent
5










